Association of IGF۲R۳′UTR(C>A) Polymorphism in M۶P/IGF۲ Receptor Gene with Insulin Resistance Indices in Diabetic Type ۲ Patients and Non Diabetic Population

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 332

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-23-96_009

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and objective: Association of ۶q loci, where IGF۲R gene is located, with insulin resistance has been well established. In this study, relationship between ۳chr('۳۹')UTR and type ۲ diabetes and insulin resistance indices in non diabetic subjects was investigated. Materials and Methods: ۳۵۰ participants (۱۷۵ diabetic type ۲ patient and ۱۷۵ non-diabetic individuals) were entered in this study. Demographic data were collected. BMI and serum levels of glucose, lipid profiles and IGF۲ of all participants were measured. Genotype polymorphism of studied participants was determined by PCR-RFLP method. Then, the relationship between genotypes and insulin resistance indices was measured and analyzed using statistical procedures of ANOVA and post hoc analysis. Results: The genotypes frequency comprised CC (۶.۸۵%), AA (۳۳.۴۵%), and CA (۵۹.۵۵%), indicating that the frequency of carrier with CA genotype polymorphism was significantly (P<۰.۰۵) higher in type ۲ diabetic patients (۸۰.۶%) than in non-diabetic participants. Serum FBS levels of CA carriers were significantly (P=۰.۰۰۱) higher than carriers of other two genotypes (CC and AA). The mean levels of serum IGF۲ in participants carrying CC and CA genotypes were significantly (P= ۰.۰۰۱) more than other participants carrying genotype AA. Conclusion: (C>A) IGF۲R۳′UTR polymorphism was associated with type ۲ diabetes and some insulin resistance indices especially FBS. However, the A allele may have a protective effect on developing type ۲ diabetes. References ۱- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for ۲۰۱۰ and ۲۰۳۰. Diabetes Res Clin Pract. ۲۰۱۰ ۸۷: ۴-۱۴. ۲- Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of diabetes mellitus in U.S. youth in ۲۰۰۹: The search for diabetes in youth study. Diabetes Care. ۲۰۱۴ ۳۷: ۴۰۲-۸. ۳- Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world — a growing challenge. N Engl J Med. ۲۰۰۷ ۱۸: ۲۱۳-۵. ۴- Hegele RA, Pollex RL. Gentic and physiological insights into metabolic syndrome. Am J Physiol Regul Integr Comp Physiol. ۲۰۰۵ ۲۸۹: ۶۶۳-۹. ۵- Tritos NA, Mantzoros CS. Clinical review ۹۷: syndromes of severe insulin resistance. J Clin Endocrinol Metab. ۱۹۹۸ ۸۳: ۳۰۲۵-۳۰. ۶- Laureys G, Barton DE, Ullrich A, Francke U. Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose ۶-phosphate receptor in man and mouse. Genomics. ۱۹۸۸ ۳: ۲۲۴-۲۹. ۷- Riesewijk AM, Xu YQ, Schepens MT, et al. Absence of an obvious molecular imprinting mechanism in a human fetus with monoallelic IGF۲R expression. Biochem Biophys Res Commun. ۱۹۹۸ ۲۴۵: ۲۷۲-۷۷. ۸- Brown J, Gilbert R, Delanie C. Structure and functional analysis of the IGF-II/IGF۲R interaction. EMBO J. ۲۰۰۸ ۲۷: ۲۶۵-۷۶. ۹- Ong KK, Dunger DB. Developmental aspects in the pathogenesis of type ۲ diabetes. Mol Cell Endocrinol. ۲۰۰۱ ۱۸۵: ۱۴۵-۴۹. ۱۰- Müller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. ۲۰۱۲ ۱۳: ۶-۱۳ ۱۱- Ludwig T, Eggenschwiler J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type ۲ IGF receptor (IGF۲R) are rescued from perinatal lethality in IGF۲ and IGF۱R null backgrounds. Developmental Biology. ۱۹۹۶ ۱۷۷: ۵۱۷-۳۵. ۱۲- Binici DN, Karaman A, Coşkun M, Oğlu AU, Uçar F. Genomic damage in patients with type-۲ diabetes mellitus. Genet Couns. ۲۰۱۳ ۲۴:۱۴۹-۵۶. ۱۳- Duggirala R, Blangero J, Almasy L, et al. A major locus for fasting insulin concentrations and insulin resistance on chromosome ۶q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet. ۲۰۰۱ ۶۸: ۱۱۴۹-۶۴. ۱۴- Villuendas G, Carretero JIB, Bermejo AL, et al. The ACAA-insertion/deletion polymorphism at the ۳۰ UTR of the IGF-II receptor gene is associated with type ۲ diabetes and surrogate markers of insulin resistance. Eur J Endocrin. ۲۰۰۶ ۱۵۵: ۳۳۱-۳۶. ۱۵- Lv K, Guo Y, Zhang Y, Wang K, Jia K, Sun S. Allele-specific targeting of hsa-miR-۶۵۷ to human IGF۲R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type ۲ diabetes. Biochem Biophys Res Commun. ۲۰۰۸ ۳۷۴: ۱۰۱-۵. ۱۶- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. ۱. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med ۱۹۹۸ ۱۵: ۵۳۹-۵۳. ۱۷- Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. ۲۰۰۵ ۲۵۴: ۵۵۵-۶۳. ۱۸- Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. ۱۹۹۹ ۲۲:۱۴۶۲-۷۰. ۱۹- Fridwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. ۱۹۷۲ ۱۸: ۴۹۹-۵۰۲. ۲۰- Bloomgarden MD. Concepts of insulin resistance. Metab Synd Related Disord. ۲۰۰۵ ۳: ۲۸۴-۹۳. ۲۱- Bouche C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type ۲ diabetes. Endocr Rev. ۲۰۰۴ ۲۵: ۸۰۷-۳۰. ۲۲- San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type ۲ diabetes mellitus, and obesity. J Clin Endocrinol Metab. ۲۰۰۴ ۸۹: ۲۶۴۰-۴۶. ۲۴- Di Bacco A, Gill G. The secreted glycoprotein CREG inhibits cell growth dependent on the ۵ mannose-۶-phosphate/insulin-like growth factor II receptor. Oncogene. ۲۰۰۳ ۲۲: ۵۴۳۶-۴۵.

Authors

فاطمه مجیدی

Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan , Iran ,Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

حسین چیتی

Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan , Iran

علی رمضانی

Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

مجتبی فتحی

Dept of Biochemistry, Zanjan University of Medical Sciences, Zanjan, Iran

رضا سلمانی

Zanjan University of Medical Sciences, Zanjan, Iran

علی اوسط ملتی

Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan , Iran Dept of Biochemistry, Zanjan University of Medical Sciences, Zanjan, Iran